Verinurad |
| Katalog-Nr.GC19373 |
Verinurad (RDEA3170) ist ein hochpotenter und spezifischer URAT1-Inhibitor mit einem IC50 von 25 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1352792-74-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Verinurad is an urate transporter inhibitor with EC50 value of 0.05 uM.IC50 value: 0.05 uM (EC50)Target: urate transporterVerinurad is useful in the modulation of blood or serum uric acid levels, reducing serum uric acid levels in a human.
References:
[1]. Yeh Li-Tain, et al. 3,4-Di-substituted pyridine compound, methods of use and compositions comprising the same. From PCT Int. Appl. (2013), WO 2013067425 A1 20130510.
[2]. Ouk, Samedy, et al. Thioacetate compounds as URAT-1 agonists and their preparation, compositions and methods of use. From PCT Int. Appl. (2011), WO 2011159839 A2 20111222.
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *